{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T05:19:15Z","timestamp":1795151955429,"version":"4.10.3"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FDM201806006523"],"award-info":[{"award-number":["FDM201806006523"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Muscle regeneration is a physiological process that converts satellite cells into mature myotubes under the influence of an inflammatory environment progressively replaced by an anti-inflammatory environment, with precise crosstalk between immune and muscular cells. If the succession of these phases is disturbed, the immune system can sometimes become auto-reactive, leading to chronic muscular inflammatory diseases, such as myositis. The triggers of these autoimmune myopathies remain mostly unknown, but the main mechanisms of pathogenesis are partially understood. They involve chronic inflammation, which could be associated with an auto-reactive immune response, and gradually with a decrease in the regenerative capacities of the muscle, leading to its degeneration, fibrosis and vascular architecture deterioration. Immunosuppressive treatments can block the first part of the process, but sometimes muscle remains weakened, or even still deteriorates, due to the exhaustion of its capacities. For patients refractory to immunosuppressive therapies, mesenchymal stem cells have shown interesting effects but their use is limited by their availability. Stromal vascular fraction, which can easily be extracted from adipose tissue, has shown good tolerance and possible therapeutic benefits in several degenerative and autoimmune diseases. However, despite the increasing use of stromal vascular fraction, the therapeutically active components within this heterogeneous cellular product are ill-defined and the mechanisms by which this therapy might be active remain insufficiently understood. We review herein the current knowledge on the mechanisms of action of stromal vascular fraction and hypothesise on how it could potentially respond to some of the unmet treatment needs of refractory myositis.<\/jats:p>","DOI":"10.1038\/s41420-023-01605-9","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T03:02:37Z","timestamp":1695092557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Stromal vascular fraction in the treatment of myositis"],"prefix":"10.1038","volume":"9","author":[{"given":"S.","family":"Gandolfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1848-6566","authenticated-orcid":false,"given":"B.","family":"Pileyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Drouot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Dubus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Auquit-Auckbur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Martinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"1605_CR1","first-page":"25","volume":"13","author":"W Yang","year":"2018","unstructured":"Yang W, Hu P. Skeletal muscle regeneration is modulated by inflammation. J Orthop Transl. 2018;13:25\u201332.","journal-title":"J Orthop Transl."},{"key":"1605_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","volume":"43","author":"Y Allenbach","year":"2017","unstructured":"Allenbach Y, Benveniste O, Goebel H-H, Stenzel W. Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol. 2017;43:62\u201381.","journal-title":"Neuropathol Appl Neurobiol."},{"key":"1605_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2017.03.005","volume":"85","author":"A Meyer","year":"2018","unstructured":"Meyer A, Lannes B, Goetz J, Echaniz-Laguna A, Lipsker D, Arnaud L, et al. Inflammatory myopathies: a new landscape. Jt Bone Spine. 2018;85:23\u201333.","journal-title":"Jt Bone Spine"},{"key":"1605_CR4","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","volume":"134","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, Guiguet M, Freebody J, Dubourg O, Squier W, Maisonobe T, et al. Long-term observational study of sporadic inclusion body myositis. Brain J Neurol. 2011;134:3176\u201384.","journal-title":"Brain J Neurol"},{"key":"1605_CR5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11926-018-0755-z","volume":"20","author":"D Jabari","year":"2018","unstructured":"Jabari D, Vedanarayanan VV, Barohn RJ, Dimachkie MM. Update on inclusion body myositis. Curr Rheumatol Rep. 2018;20:52.","journal-title":"Curr Rheumatol Rep."},{"key":"1605_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","volume":"14","author":"CV Oddis","year":"2018","unstructured":"Oddis CV, Aggarwal R. Treatment in myositis. Nat Rev Rheumatol. 2018;14:279\u201389.","journal-title":"Nat Rev Rheumatol."},{"key":"1605_CR7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2141.2000.02191.x","volume":"110","author":"F Baron","year":"2000","unstructured":"Baron F, Ribbens C, Kaye O, Fillet G, Malaise M, Beguin Y. Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol. 2000;110:339\u201342.","journal-title":"Br J Haematol"},{"key":"1605_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12969-018-0284-3","volume":"16","author":"J Zhu","year":"2018","unstructured":"Zhu J, Su G, Lai J, Dong B, Kang M, Li S, et al. Long-term follow-up of autologous hematopoietic stem cell transplantation for refractory juvenile dermatomyositis: a case-series study. Pediatr Rheumatol. 2018;16:72.","journal-title":"Pediatr Rheumatol."},{"key":"1605_CR9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2008.094755","volume":"68","author":"JC Henes","year":"2009","unstructured":"Henes JC, Heinzelmann F, Wacker A, Seelig HP, Klein R, Bornemann A, et al. Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantation. Ann Rheum Dis. 2009;68:447\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1605_CR10","first-page":"979","volume":"30","author":"FB Salvador","year":"2012","unstructured":"Salvador FB, Isenberg DA. Use of autologous stem cell transplantation in adult patients with idiopathic inflammatory myopathies: a case-report and review of the literature. Clin Exp Rheumatol. 2012;30:979.","journal-title":"Clin Exp Rheumatol."},{"key":"1605_CR11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13287-018-1053-4","volume":"9","author":"J Liang","year":"2018","unstructured":"Liang J, Zhang H, Kong W, Deng W, Wang D, Feng X, et al. Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study. Stem Cell Res Ther. 2018;9:312.","journal-title":"Stem Cell Res Ther"},{"key":"1605_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"P Bourin","year":"2013","unstructured":"Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641\u20138.","journal-title":"Cytotherapy"},{"key":"1605_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211\u201328.","journal-title":"Tissue Eng"},{"key":"1605_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13287-017-0598-y","volume":"8","author":"P Bora","year":"2017","unstructured":"Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8:145.","journal-title":"Stem Cell Res Ther"},{"key":"1605_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphys.2020.00087","volume":"11","author":"EE Howard","year":"2020","unstructured":"Howard EE, Pasiakos SM, Blesso CN, Fussell MA, Rodriguez NR. Divergent roles of inflammation in skeletal muscle recovery from injury. Front Physiol. 2020;11:87.","journal-title":"Front Physiol."},{"key":"1605_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-065X.2007.00574.x","volume":"220","author":"ME Bianchi","year":"2007","unstructured":"Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35\u201346.","journal-title":"Immunol Rev."},{"key":"1605_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0022-510X(95)00255-Z","volume":"135","author":"JR Gorospe","year":"1996","unstructured":"Gorospe JR, Nishikawa BK, Hoffman EP. Recruitment of mast cells to muscle after mild damage. J Neurol Sci. 1996;135:10\u201317.","journal-title":"J Neurol Sci."},{"key":"1605_CR18","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1152\/ajpcell.1993.265.1.C166","volume":"265","author":"RA Fielding","year":"1993","unstructured":"Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ, Cannon JG. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am J Physiol. 1993;265:R166\u201372.","journal-title":"Am J Physiol"},{"key":"1605_CR19","first-page":"457","volume":"41","author":"TA Butterfield","year":"2006","unstructured":"Butterfield TA, Best TM, Merrick MA. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train. 2006;41:457\u201365.","journal-title":"J Athl Train."},{"key":"1605_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491.","journal-title":"Front Immunol."},{"key":"1605_CR21","doi-asserted-by":"crossref","first-page":"C1183","DOI":"10.1152\/ajpcell.00568.2007","volume":"294","author":"M Cheng","year":"2008","unstructured":"Cheng M, Nguyen M-H, Fantuzzi G, Koh TJ. Endogenous interferon-gamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol. 2008;294:C1183\u201391.","journal-title":"Am J Physiol Cell Physiol."},{"key":"1605_CR22","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.1303486","volume":"193","author":"J Zhang","year":"2014","unstructured":"Zhang J, Xiao Z, Qu C, Cui W, Wang X, Du J. CD8 T cells are involved in skeletal muscle regeneration through facilitating MCP-1 secretion and Gr1(high) macrophage infiltration. J Immunol. 2014;193:5149\u201360.","journal-title":"J Immunol"},{"key":"1605_CR23","doi-asserted-by":"crossref","first-page":"438675","DOI":"10.1155\/2014\/438675","volume":"2014","author":"L Madaro","year":"2014","unstructured":"Madaro L, Bouch\u00e9 M. From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes. BioMed Res Int. 2014;2014:438675.","journal-title":"BioMed Res Int."},{"key":"1605_CR24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/cr.2015.58","volume":"25","author":"X Fu","year":"2015","unstructured":"Fu X, Xiao J, Wei Y, Li S, Liu Y, Yin J, et al. Combination of inflammation-related cytokines promotes long-term muscle stem cell expansion. Cell Res. 2015;25:655\u201373.","journal-title":"Cell Res"},{"key":"1605_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-385940-2.00004-8","volume":"96","author":"JM Peterson","year":"2011","unstructured":"Peterson JM, Bakkar N, Guttridge DC. NF-\u03baB signaling in skeletal muscle health and disease. Curr Top Dev Biol. 2011;96:85\u2013119.","journal-title":"Curr Top Dev Biol"},{"key":"1605_CR26","doi-asserted-by":"crossref","first-page":"C1660","DOI":"10.1152\/ajpcell.00486.2006","volume":"292","author":"S-E Chen","year":"2007","unstructured":"Chen S-E, Jin B, Li Y-P. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol. 2007;292:C1660\u201371.","journal-title":"Am J Physiol Cell Physiol."},{"key":"1605_CR27","doi-asserted-by":"crossref","first-page":"C1179","DOI":"10.1152\/ajpcell.00062.2005","volume":"289","author":"S-E Chen","year":"2005","unstructured":"Chen S-E, Gerken E, Zhang Y, Zhan M, Mohan RK, Li AS, et al. Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle. Am J Physiol Cell Physiol. 2005;289:C1179\u201387.","journal-title":"Am J Physiol Cell Physiol."},{"key":"1605_CR28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1096\/fj.02-0187fje","volume":"16","author":"GL Warren","year":"2002","unstructured":"Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, Luster MI, et al. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J. 2002;16:1630\u20132.","journal-title":"FASEB J"},{"key":"1605_CR29","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1111\/febs.12338","volume":"280","author":"P Mu\u00f1oz-C\u00e1noves","year":"2013","unstructured":"Mu\u00f1oz-C\u00e1noves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280:4131\u201348.","journal-title":"FEBS J"},{"key":"1605_CR30","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1152\/ajpregu.00310.2017","volume":"315","author":"C Chaweewannakorn","year":"2018","unstructured":"Chaweewannakorn C, Tsuchiya M, Koide M, Hatakeyama H, Tanaka Y, Yoshida S, et al. Roles of IL-1\u03b1\/\u03b2 in regeneration of cardiotoxin-injured muscle and satellite cell function. Am J Physiol Regul Integr Comp Physiol. 2018;315:R90\u2013103.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"1605_CR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23\u201335.","journal-title":"Nat Rev Immunol."},{"key":"1605_CR32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","volume":"153","author":"JE Heredia","year":"2013","unstructured":"Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM, et al. Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration. Cell. 2013;153:376\u201388.","journal-title":"Cell"},{"key":"1605_CR33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/cdd.2015.171","volume":"23","author":"C Sciorati","year":"2016","unstructured":"Sciorati C, Rigamonti E, Manfredi AA, Rovere-Querini P. Cell death, clearance and immunity in the skeletal muscle. Cell Death Differ. 2016;23:927\u201337.","journal-title":"Cell Death Differ"},{"key":"1605_CR34","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1242\/jcs.026534","volume":"121","author":"A Otto","year":"2008","unstructured":"Otto A, Schmidt C, Luke G, Allen S, Valasek P, Muntoni F, et al. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci. 2008;121:2939\u201350.","journal-title":"J Cell Sci"},{"key":"1605_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","volume":"7","author":"AL Serrano","year":"2008","unstructured":"Serrano AL, Baeza-Raja B, Perdiguero E, Jard\u00ed M, Mu\u00f1oz-C\u00e1noves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7:33\u201344.","journal-title":"Cell Metab"},{"key":"1605_CR36","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","volume":"155","author":"D Burzyn","year":"2013","unstructured":"Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, et al. A special population of regulatory T cells potentiates muscle repair. Cell. 2013;155:1282\u201395.","journal-title":"Cell"},{"key":"1605_CR37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","volume":"44","author":"W Kuswanto","year":"2016","unstructured":"Kuswanto W, Burzyn D, Panduro M, Wang KK, Jang YC, Wagers AJ, et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent, accumulation of regulatory T cells. Immunity. 2016;44:355\u201367.","journal-title":"Immunity"},{"key":"1605_CR38","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Ren B, Wang D, Lin H. Regulatory T cells in skeletal muscle repair and regeneration: recent insights. Cell Death Dis. 2022;13:680.","journal-title":"Cell Death Dis"},{"key":"1605_CR39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.0504272","volume":"76","author":"RD Stout","year":"2004","unstructured":"Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol. 2004;76:509\u201313.","journal-title":"J Leukoc Biol."},{"key":"1605_CR40","doi-asserted-by":"crossref","first-page":"17475","DOI":"10.1073\/pnas.0908641106","volume":"106","author":"D Ruffell","year":"2009","unstructured":"Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, et al. A CREB-C\/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci USA. 2009;106:17475\u201380.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1605_CR41","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","volume":"21","author":"DR Lemos","year":"2015","unstructured":"Lemos DR, Babaeijandaghi F, Low M, Chang C-K, Lee ST, Fiore D, et al. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors. Nat Med. 2015;21:786\u201394.","journal-title":"Nat Med."},{"key":"1605_CR42","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","volume":"304","author":"NJ Pillon","year":"2013","unstructured":"Pillon NJ, Bilan PJ, Fink LN, Klip A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab. 2013;304:E453\u201365.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"1605_CR43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1091\/mbc.e06-08-0693","volume":"18","author":"C Christov","year":"2007","unstructured":"Christov C, Chr\u00e9tien F, Abou-Khalil R, Bassez G, Vallet G, Authier F-J, et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell. 2007;18:1397\u2013409.","journal-title":"Mol Biol Cell"},{"key":"1605_CR44","doi-asserted-by":"crossref","DOI":"10.1186\/s13062-021-00306-6","volume":"16","author":"J Fang","year":"2021","unstructured":"Fang J, Feng C, Chen W, Hou P, Liu Z, Zuo M, et al. Redressing the interactions between stem cells and immune system in tissue regeneration. Biol Direct. 2021;16:18.","journal-title":"Biol Direct"},{"key":"1605_CR45","doi-asserted-by":"crossref","first-page":"e134189","DOI":"10.1172\/jci.insight.134189","volume":"5","author":"N Seto","year":"2020","unstructured":"Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, et al. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight. 2020;5:e134189.","journal-title":"JCI Insight"},{"key":"1605_CR46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-018-1632-x","volume":"20","author":"S Gao","year":"2018","unstructured":"Gao S, Zuo X, Liu D, Xiao Y, Zhu H, Zhang H, et al. The roles of neutrophil serine proteinases in idiopathic inflammatory myopathies. Arthritis Res Ther. 2018;20:134.","journal-title":"Arthritis Res Ther."},{"key":"1605_CR47","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/NEN.0b013e3181e10925","volume":"69","author":"J Reimann","year":"2010","unstructured":"Reimann J, Schnell S, Schwartz S, Kappes-Horn K, Dodel R, Bacher M. Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies. J Neuropathol Exp Neurol. 2010;69:654\u201362.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1605_CR48","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","volume":"181","author":"C Preu\u00dfe","year":"2012","unstructured":"Preu\u00dfe C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, et al. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am J Pathol. 2012;181:2161\u201371.","journal-title":"Am J Pathol."},{"key":"1605_CR49","doi-asserted-by":"crossref","first-page":"e88788","DOI":"10.1371\/journal.pone.0088788","volume":"9","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, Chaara W, Rosenzwajg M, Six A, Prevel N, Mingozzi F, et al. Th1 response and systemic treg deficiency in inclusion body myositis. PLoS ONE. 2014;9:e88788.","journal-title":"PLoS ONE"},{"key":"1605_CR50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12445","volume":"178","author":"EM Moran","year":"2014","unstructured":"Moran EM, Mastaglia FL. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin Exp Immunol. 2014;178:405\u201315.","journal-title":"Clin Exp Immunol"},{"key":"1605_CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gene.2011.61","volume":"13","author":"SA Greenberg","year":"2012","unstructured":"Greenberg SA, Higgs BW, Morehouse C, Walsh RJ, Kong SW, Brohawn P, et al. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes Immun. 2012;13:207\u201313.","journal-title":"Genes Immun"},{"key":"1605_CR52","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awy105","volume":"141","author":"L Ladislau","year":"2018","unstructured":"Ladislau L, Su\u00e1rez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M, et al. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain J Neurol. 2018;141:1609\u201321.","journal-title":"Brain J Neurol"},{"key":"1605_CR53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel G, Page G, Granet C, Streichenberger N, Varennes A, Miossec P. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol. 2003;137:125\u201333.","journal-title":"J Neuroimmunol."},{"key":"1605_CR54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajpath.2013.06.003","volume":"183","author":"M Fr\u00e9ret","year":"2013","unstructured":"Fr\u00e9ret M, Drouot L, Obry A, Ahmed-Lacheheb S, Dauly C, Adriouch S, et al. Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response. Am J Pathol. 2013;183:893\u2013904.","journal-title":"Am J Pathol."},{"key":"1605_CR55","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheumatol. 2005;52:1824\u201335.","journal-title":"Arthritis Rheumatol"},{"key":"1605_CR56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","volume":"50","author":"G Page","year":"2004","unstructured":"Page G, Chevrel G, Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheumatol. 2004;50:199\u2013208.","journal-title":"Arthritis Rheumatol"},{"key":"1605_CR57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41420-022-01282-0","volume":"8","author":"S Wang","year":"2022","unstructured":"Wang S, Wang H, Feng C, Li C, Li Z, He J, et al. The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases. Cell Death Discov. 2022;8:492.","journal-title":"Cell Death Discov"},{"key":"1605_CR58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/mus.21739","volume":"42","author":"M Salajegheh","year":"2010","unstructured":"Salajegheh M, Pinkus JL, Amato AA, Morehouse C, Jallal B, Yao Y, et al. Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle Nerve. 2010;42:576\u201383.","journal-title":"Muscle Nerve"},{"key":"1605_CR59","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1212\/NXI.0000000000000451","volume":"5","author":"J Radke","year":"2018","unstructured":"Radke J, Koll R, Preu\u00dfe C, Pehl D, Todorova K, Sch\u00f6nemann C, et al. Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis. Neurol Neuroimmunol Neuroinflamm. 2018;5:e451.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1605_CR60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fneur.2019.00438","volume":"10","author":"B Stuhlm\u00fcller","year":"2019","unstructured":"Stuhlm\u00fcller B, Schneider U, Gonz\u00e1lez-Gonz\u00e1lez J-B, Feist E. Disease specific autoantibodies in idiopathic inflammatory myopathies. Front Neurol. 2019;10:438.","journal-title":"Front Neurol."},{"key":"1605_CR61","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","volume":"81","author":"L Arouche-Delaperche","year":"2017","unstructured":"Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, et al. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol. 2017;81:538\u201348.","journal-title":"Ann Neurol."},{"key":"1605_CR62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2018-213518","volume":"78","author":"C Bergua","year":"2019","unstructured":"Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, et al. In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Ann Rheum Dis. 2019;78:131\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1605_CR63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/cei.12311","volume":"177","author":"T Fujiyama","year":"2014","unstructured":"Fujiyama T, Ito T, Ogawa N, Suda T, Tokura Y, Hashizume H. Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis. Clin Exp Immunol. 2014;177:110\u201320.","journal-title":"Clin Exp Immunol"},{"key":"1605_CR64","first-page":"49","volume":"27","author":"KM Rostasy","year":"2008","unstructured":"Rostasy KM, Schmidt J, Bahn E, Pfander T, Piepkorn M, Wilichowski E, et al. Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies. Acta Myol. 2008;27:49\u201353.","journal-title":"Acta Myol."},{"key":"1605_CR65","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/mus.25405","volume":"55","author":"S Noda","year":"2017","unstructured":"Noda S, Koike H, Maeshima S, Nakanishi H, Iijima M, Matsuo K, et al. Transforming growth factor-\u03b2 signaling is upregulated in sporadic inclusion body myositis. Muscle Nerve. 2017;55:741\u20137.","journal-title":"Muscle Nerve"},{"key":"1605_CR66","doi-asserted-by":"crossref","DOI":"10.1186\/2044-5040-1-19","volume":"1","author":"TN Burks","year":"2011","unstructured":"Burks TN, Cohn RD. Role of TGF-\u03b2 signaling in inherited and acquired myopathies. Skelet Muscle. 2011;1:19.","journal-title":"Skelet Muscle"},{"key":"1605_CR67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00005072-199705000-00003","volume":"56","author":"P Confalonieri","year":"1997","unstructured":"Confalonieri P, Bernasconi P, Cornelio F, Mantegazza R. Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J Neuropathol Exp Neurol. 1997;56:479\u201384.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1605_CR68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20289-8","volume":"12","author":"F Girardi","year":"2021","unstructured":"Girardi F, Taleb A, Ebrahimi M, Datye A, Gamage DG, Peccate C, et al. TGF\u03b2 signaling curbs cell fusion and muscle regeneration. Nat Commun. 2021;12:750.","journal-title":"Nat Commun."},{"key":"1605_CR69","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1242\/jcs.086629","volume":"124","author":"A Uezumi","year":"2011","unstructured":"Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci. 2011;124:3654\u201364.","journal-title":"J Cell Sci"},{"key":"1605_CR70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41467-020-14734-x","volume":"11","author":"Y Saito","year":"2020","unstructured":"Saito Y, Chikenji TS, Matsumura T, Nakano M, Fujimiya M. Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors. Nat Commun. 2020;11:889.","journal-title":"Nat Commun"},{"key":"1605_CR71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nmd.2012.09.003","volume":"23","author":"JV Wanschitz","year":"2013","unstructured":"Wanschitz JV, Dubourg O, Lacene E, Fischer MB, H\u00f6ftberger R, Budka H, et al. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis. Neuromuscul Disord. 2013;23:75\u201383.","journal-title":"Neuromuscul Disord"},{"key":"1605_CR72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/febs.13827","volume":"284","author":"S Schiaffino","year":"2017","unstructured":"Schiaffino S, Pereira MG, Ciciliot S, Rovere-Querini P. Regulatory T cells and skeletal muscle regeneration. FEBS J. 2017;284:517\u201324.","journal-title":"FEBS J"},{"key":"1605_CR73","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/BOR.0b013e3283319265","volume":"21","author":"A Henriques-Pons","year":"2009","unstructured":"Henriques-Pons A, Nagaraju K. Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis. Curr Opin Rheumatol. 2009;21:581\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"1605_CR74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","volume":"129","author":"O Benveniste","year":"2015","unstructured":"Benveniste O, Stenzel W, Hilton-Jones D, Sandri M, Boyer O, van Engelen BGM. Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol. 2015;129:611\u201324.","journal-title":"Acta Neuropathol"},{"key":"1605_CR75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2796.2010.02334.x","volume":"269","author":"I Loell","year":"2011","unstructured":"Loell I, Lundberg IE. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? J Intern Med. 2011;269:243\u201357.","journal-title":"J Intern Med"},{"key":"1605_CR76","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neurobiolaging.2008.08.011","volume":"31","author":"R Morosetti","year":"2010","unstructured":"Morosetti R, Broccolini A, Sancricca C, Gliubizzi C, Gidaro T, Tonali PA, et al. Increased aging in primary muscle cultures of sporadic inclusion-body myositis. Neurobiol Aging. 2010;31:1205\u201314.","journal-title":"Neurobiol Aging"},{"key":"1605_CR77","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40674-018-0106-2","volume":"4","author":"S Barsotti","year":"2018","unstructured":"Barsotti S, Lundberg IE. Current treatment for myositis. Curr Treat Options Rheumatol. 2018;4:299\u2013315.","journal-title":"Curr Treat Options Rheumatol."},{"key":"1605_CR78","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","volume":"45","author":"O Schakman","year":"2013","unstructured":"Schakman O, Kalista S, Barb\u00e9 C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013;45:2163\u201372.","journal-title":"Int J Biochem Cell Biol."},{"key":"1605_CR79","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40620-019-00602-5","volume":"32","author":"C Ponticelli","year":"2019","unstructured":"Ponticelli C, Glassock RJ. Prevention of complications from use of conventional immunosuppressants: a critical review. J Nephrol. 2019;32:851\u201370.","journal-title":"J Nephrol."},{"key":"1605_CR80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00296-019-04467-6","volume":"40","author":"T Khoo","year":"2020","unstructured":"Khoo T, Limaye V. Biologic therapy in the idiopathic inflammatory myopathies. Rheumatol Int. 2020;40:191\u2013205.","journal-title":"Rheumatol Int."},{"key":"1605_CR81","doi-asserted-by":"publisher","unstructured":"Paik JJ, Casciola-Rosen L, Shin JY, Albayda J, Tiniakou E, Leung DG, et al. Study of tofacitinib in refractory dermatomyositis (STIR): an open label pilot study of 10 patients. Arthritis Rheumatol. 2020. https:\/\/doi.org\/10.1002\/art.41602.","DOI":"10.1002\/art.41602"},{"key":"1605_CR82","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.3390\/biomedicines10082036","volume":"10","author":"S Julien","year":"2022","unstructured":"Julien S, Vadysirisack D, Sayegh C, Ragunathan S, Tang Y, Briand E, et al. Prevention of anti-HMGCR immune-mediated necrotising myopathy by C5 complement inhibition in a humanised mouse model. Biomedicines. 2022;10:2036.","journal-title":"Biomedicines"},{"key":"1605_CR83","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2665-9913(23)00003-6","volume":"5","author":"AL Mammen","year":"2023","unstructured":"Mammen AL, Amato AA, Dimachkie MM, Chinoy H, Hussain Y, Lilleker JB, et al. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatol. 2023;5:e67\u201376.","journal-title":"Lancet Rheumatol"},{"key":"1605_CR84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/BOR.0000000000000436","volume":"29","author":"K Schmidt","year":"2017","unstructured":"Schmidt K, Schmidt J. Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment. Curr Opin Rheumatol. 2017;29:632\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"1605_CR85","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3803\/EnM.2020.405","volume":"35","author":"T Dao","year":"2020","unstructured":"Dao T, Green AE, Kim YA, Bae S-J, Ha K-T, Gariani K, et al. Sarcopenia and muscle aging: a brief overview. Endocrinol Metab. 2020;35:716\u201332.","journal-title":"Endocrinol Metab."},{"key":"1605_CR86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med."},{"key":"1605_CR87","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","volume":"70","author":"D Wang","year":"2011","unstructured":"Wang D, Zhang H, Cao M, Tang Y, Liang J, Feng X, et al. Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis. 2011;70:1285\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1605_CR88","first-page":"2186","volume":"14","author":"Q Lai","year":"2015","unstructured":"Lai Q, Yu L, Qiu Y, Chen L, Huang J, Li Y, et al. Umbilical cord blood mesenchymal stem cells transplantion for polymyositis\/dermatomyositis:variation of Th cytokines. Chin J Tissue Eng Res. 2015;14:2186\u201391.","journal-title":"Chin J Tissue Eng Res"},{"key":"1605_CR89","volume":"9","author":"JC Ra","year":"2011","unstructured":"Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, et al. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med. 2011;9:181.","journal-title":"J Transl Med."},{"key":"1605_CR90","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcell.2019.00088","volume":"7","author":"L Senesi","year":"2019","unstructured":"Senesi L, De Francesco F, Farinelli L, Manzotti S, Gagliardi G, Papalia GF, et al. Mechanical and enzymatic procedures to isolate the stromal vascular fraction from adipose tissue: preliminary results. Front Cell Dev Biol. 2019;7:88.","journal-title":"Front Cell Dev Biol."},{"key":"1605_CR91","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1097\/GOX.0000000000001017","volume":"4","author":"A Cond\u00e9-Green","year":"2016","unstructured":"Cond\u00e9-Green A, Kotamarti VS, Sherman LS, Keith JD, Lee ES, Granick MS, et al. Shift toward mechanical isolation of adipose-derived stromal vascular fraction: review of upcoming techniques. Plast Reconstr Surg Glob Open. 2016;4:e1017.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"1605_CR92","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1002\/term.2407","volume":"12","author":"JA van Dongen","year":"2018","unstructured":"van Dongen JA, Tuin AJ, Spiekman M, Jansma J, van der Lei B, Harmsen MC. Comparison of intraoperative procedures for isolation of clinical grade stromal vascular fraction for regenerative purposes: a systematic review. J Tissue Eng Regen Med. 2018;12:e261\u201374.","journal-title":"J Tissue Eng Regen Med."},{"key":"1605_CR93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/PRS.0000000000003214","volume":"139","author":"Y Yao","year":"2017","unstructured":"Yao Y, Dong Z, Liao Y, Zhang P, Ma J, Gao J, et al. Adipose extracellular matrix\/stromal vascular fraction gel: a novel adipose tissue-derived injectable for stem cell therapy. Plast Reconstr Surg. 2017;139:867\u201379.","journal-title":"Plast Reconstr Surg"},{"key":"1605_CR94","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibtech.2015.06.001","volume":"33","author":"MW Laschke","year":"2015","unstructured":"Laschke MW, Menger MD. Adipose tissue-derived microvascular fragments: natural vascularization units for regenerative medicine. Trends Biotechnol. 2015;33:442\u20138.","journal-title":"Trends Biotechnol"},{"key":"1605_CR95","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/sctm.17-0031","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, J\u00f8rgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, S\u00f8rensen JA. Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events. Stem Cells Transl Med. 2017;6:1786\u201394.","journal-title":"Stem Cells Transl Med"},{"key":"1605_CR96","doi-asserted-by":"crossref","first-page":"e019414","DOI":"10.1136\/bmjopen-2017-019414","volume":"8","author":"B Murdoch","year":"2018","unstructured":"Murdoch B, Zarzeczny A, Caulfield T. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites\u2019 marketing of stem cell therapies. BMJ Open. 2018;8:e019414.","journal-title":"BMJ Open"},{"key":"1605_CR97","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2217\/rme-2019-0064","volume":"14","author":"PS Knoepfler","year":"2019","unstructured":"Knoepfler PS. Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years. Regen Med. 2019;14:735\u201340.","journal-title":"Regen Med."},{"key":"1605_CR98","unstructured":"Commissioner, O of the. Innovative regenerative medicine therapies \u2013 patient safety comes first. FDA. 2021. https:\/\/www.fda.gov\/news-events\/fda-voices\/innovative-regenerative-medicine-therapies-patient-safety-comes-first."},{"key":"1605_CR99","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/14712598.2019.1671970","volume":"19","author":"I Andia","year":"2019","unstructured":"Andia I, Maffulli N, Burgos-Alonso N. Stromal vascular fraction technologies and clinical applications. Expert Opin Biol Ther. 2019;19:1289\u2013305.","journal-title":"Expert Opin Biol Ther."},{"key":"1605_CR100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/sctm.17-0282","volume":"7","author":"G Bauer","year":"2018","unstructured":"Bauer G, Elsallab M, Abou-El-Enein M. Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Stem Cells Transl Med. 2018;7:676\u201385.","journal-title":"Stem Cells Transl Med"},{"key":"1605_CR101","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BCO.0000000000000961","volume":"32","author":"JW Pritchett","year":"2021","unstructured":"Pritchett JW. The debit side of stem-cell joint injections: a prospective cohort study. Curr Orthop Pract. 2021;32:118\u201323.","journal-title":"Curr Orthop Pract"},{"key":"1605_CR102","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12015-013-9492-x","volume":"10","author":"J Ge","year":"2014","unstructured":"Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao RCH, et al. The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev Rep. 2014;10:295\u2013303.","journal-title":"Stem Cell Rev Rep."},{"key":"1605_CR103","first-page":"e975","volume":"9","author":"J Monreal","year":"2017","unstructured":"Monreal J. Functional and aesthetic recovery of congenital muscular torticollis with intramuscular stromal vascular fraction enriched fat grafting. Cureus. 2017;9:e975.","journal-title":"Cureus"},{"key":"1605_CR104","first-page":"20","volume":"1","author":"H-B Lee","year":"2019","unstructured":"Lee H-B, Park S-W, Kim J, Hwang K-C, Kim I-K, Sun H-M, et al. Intramuscular injection of adipose tissue derived stromal vascular fraction in subjects with poliomyelitis: case reports. Int J Stem Cell Res Ther. 2019;1:20\u201327.","journal-title":"Int J Stem Cell Res Ther"},{"key":"1605_CR105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcyt.2013.11.011","volume":"16","author":"A Bura","year":"2014","unstructured":"Bura A, Planat-Benard V, Bourin P, Silvestre J-S, Gross F, Grolleau J-L, et al. Phase I trial: the use of autologous cultured adipose-derived stroma\/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 2014;16:245\u201357.","journal-title":"Cytotherapy"},{"key":"1605_CR106","first-page":"1750","volume":"76","author":"HC Lee","year":"2012","unstructured":"Lee HC, An SG, Lee HW, Park J-S, Cha KS, Hong TJ, et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J J Jpn Circ Soc. 2012;76:1750\u201360.","journal-title":"Circ J J Jpn Circ Soc."},{"key":"1605_CR107","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/sctm.18-0208","volume":"8","author":"S Hamidian Jahromi","year":"2019","unstructured":"Hamidian Jahromi S, Davies JE. Concise review: skeletal muscle as a delivery route for mesenchymal stromal cells. Stem Cells Transl Med. 2019;8:456\u201365.","journal-title":"Stem Cells Transl Med"},{"key":"1605_CR108","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jcyt.2017.09.013","volume":"20","author":"LR Braid","year":"2018","unstructured":"Braid LR, Wood CA, Wiese DM, Ford BN. Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes. Cytotherapy. 2018;20:232\u201344.","journal-title":"Cytotherapy"},{"key":"1605_CR109","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/scd.2017.0248","volume":"27","author":"S Hamidian Jahromi","year":"2018","unstructured":"Hamidian Jahromi S, Estrada C, Li Y, Cheng E, Davies JE. Human umbilical cord perivascular cells and human bone marrow mesenchymal stromal cells transplanted intramuscularly respond to a distant source of inflammation. Stem Cells Dev. 2018;27:415\u201329.","journal-title":"Stem Cells Dev"},{"key":"1605_CR110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","volume":"129","author":"B Puissant","year":"2005","unstructured":"Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129:118\u201329.","journal-title":"Br J Haematol."},{"key":"1605_CR111","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.intimp.2013.02.020","volume":"15","author":"M Najar","year":"2013","unstructured":"Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, et al. Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration. Int Immunopharmacol. 2013;15:693\u2013702.","journal-title":"Int Immunopharmacol."},{"key":"1605_CR112","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13287-015-0233-8","volume":"6","author":"N Ketterl","year":"2015","unstructured":"Ketterl N, Brachtl G, Schuh C, Bieback K, Schallmoser K, Reinisch A, et al. A robust potency assay highlights significant donor variation of human mesenchymal stem\/progenitor cell immune modulatory capacity and extended radio-resistance. Stem Cell Res Ther. 2015;6:236.","journal-title":"Stem Cell Res Ther"},{"key":"1605_CR113","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/stem.2516","volume":"35","author":"AC Bowles","year":"2017","unstructured":"Bowles AC, Strong AL, Wise RM, Thomas RC, Gerstein BY, Dutreil MF, et al. Adipose stromal vascular fraction-mediated improvements at late-stage disease in a murine model of multiple sclerosis. Stem Cells. 2017;35:532\u201344.","journal-title":"Stem Cells"},{"key":"1605_CR114","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/ten.2006.0315","volume":"13","author":"L Cui","year":"2007","unstructured":"Cui L, Yin S, Liu W, Li N, Zhang W, Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng. 2007;13:1185\u201395.","journal-title":"Tissue Eng."},{"key":"1605_CR115","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1089\/ten.tea.2008.0630","volume":"15","author":"O DelaRosa","year":"2009","unstructured":"DelaRosa O, Lombardo E, Beraza A, Manche\u00f1o-Corvo P, Ramirez C, Menta R, et al. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A. 2009;15:2795\u2013806.","journal-title":"Tissue Eng Part A"},{"key":"1605_CR116","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jcyt.2014.07.004","volume":"16","author":"R Menta","year":"2014","unstructured":"Menta R, Manche\u00f1o-Corvo P, Del R\u00edo B, Ram\u00edrez C, DelaRosa O, Dalemans W, et al. Tryptophan concentration is the main mediator of the capacity of adipose mesenchymal stromal cells to inhibit T-lymphocyte proliferation in vitro. Cytotherapy. 2014;16:1679\u201391.","journal-title":"Cytotherapy"},{"key":"1605_CR117","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12015-014-9567-3","volume":"11","author":"M Najar","year":"2015","unstructured":"Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, et al. Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during the T cell response: the importance of the IL-10\/CD210 axis. Stem Cell Rev Rep. 2015;11:442\u201352.","journal-title":"Stem Cell Rev Rep."},{"key":"1605_CR118","first-page":"436476","volume":"2014","author":"K-S Cho","year":"2014","unstructured":"Cho K-S, Park M-K, Kang S-A, Park H-Y, Hong S-L, Park H-K, et al. Adipose-derived stem cells ameliorate allergic airway inflammation by inducing regulatory T cells in a mouse model of asthma. Mediators Inflamm. 2014;2014:436476.","journal-title":"Mediators Inflamm"},{"key":"1605_CR119","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3389\/fimmu.2018.02075","volume":"9","author":"Q Zeng","year":"2018","unstructured":"Zeng Q, Sun X, Xiao L, Xie Z, Bettini M, Deng T. A unique population: adipose-resident regulatory T cells. Front Immunol. 2018;9:2075.","journal-title":"Front Immunol."},{"key":"1605_CR120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K N\u00e9meth","year":"2009","unstructured":"N\u00e9meth K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42\u20139.","journal-title":"Nat Med."},{"key":"1605_CR121","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.canlet.2019.03.051","volume":"453","author":"J Shi","year":"2019","unstructured":"Shi J, Lu P, Shen W, He R, Yang M-W, Fang Y, et al. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer. Cancer Lett. 2019;453:158\u201369.","journal-title":"Cancer Lett"},{"key":"1605_CR122","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/stem.3077","volume":"38","author":"C M\u00e9nard","year":"2020","unstructured":"M\u00e9nard C, Dulong J, Roulois D, H\u00e9braud B, Verdi\u00e8re L, Pangault C, et al. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells. 2020;38:146\u201359.","journal-title":"Stem Cells"},{"key":"1605_CR123","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stemcr.2017.02.008","volume":"8","author":"N Espagnolle","year":"2017","unstructured":"Espagnolle N, Balguerie A, Arnaud E, Senseb\u00e9 L, Varin A. CD54-mediated interaction with pro-inflammatory macrophages increases the immunosuppressive function of human mesenchymal stromal cells. Stem Cell Rep. 2017;8:961\u201376.","journal-title":"Stem Cell Rep."},{"key":"1605_CR124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175\u201384.","journal-title":"J Clin Invest."},{"key":"1605_CR125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4049\/jimmunol.172.1.567","volume":"172","author":"L Williams","year":"2004","unstructured":"Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol. 2004;172:567\u201376.","journal-title":"J Immunol"},{"key":"1605_CR126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/bfgp\/elt028","volume":"12","author":"AP Hutchins","year":"2013","unstructured":"Hutchins AP, Diez D, Miranda-Saavedra D. The IL-10\/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genom. 2013;12:489\u201398.","journal-title":"Brief Funct Genom"},{"key":"1605_CR127","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1073\/pnas.0500419102","volume":"102","author":"PJ Murray","year":"2005","unstructured":"Murray PJ. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci USA. 2005;102:8686\u201391.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1605_CR128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/bbrc.1999.1455","volume":"265","author":"Y Sato","year":"1999","unstructured":"Sato Y, Ohshima T, Kondo T. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun. 1999;265:194\u20139.","journal-title":"Biochem Biophys Res Commun."},{"key":"1605_CR129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00403-013-1314-0","volume":"305","author":"J-H Shi","year":"2013","unstructured":"Shi J-H, Guan H, Shi S, Cai W-X, Bai X-Z, Hu X-L, et al. Protection against TGF-\u03b21-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring. Arch Dermatol Res. 2013;305:341\u201352.","journal-title":"Arch Dermatol Res."},{"key":"1605_CR130","doi-asserted-by":"crossref","first-page":"e98228","DOI":"10.1371\/journal.pone.0098228","volume":"9","author":"J Shi","year":"2014","unstructured":"Shi J, Li J, Guan H, Cai W, Bai X, Fang X, et al. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K\/AKT and STAT3 signaling pathways in scar-forming fibroblasts. PLoS ONE. 2014;9:e98228.","journal-title":"PLoS ONE"},{"key":"1605_CR131","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/scrt528","volume":"5","author":"N Serratrice","year":"2014","unstructured":"Serratrice N, Bruzzese L, Magalon J, V\u00e9ran J, Giraudo L, Aboudou H, et al. New fat-derived products for treating skin-induced lesions of scleroderma in nude mice. Stem Cell Res Ther. 2014;5:138.","journal-title":"Stem Cell Res Ther"},{"key":"1605_CR132","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13287-018-0842-0","volume":"9","author":"A Mattei","year":"2018","unstructured":"Mattei A, Magalon J, Bertrand B, Grimaud F, Revis J, Velier M, et al. Autologous adipose-derived stromal vascular fraction and scarred vocal folds: first clinical case report. Stem Cell Res Ther. 2018;9:202.","journal-title":"Stem Cell Res Ther"},{"key":"1605_CR133","doi-asserted-by":"crossref","first-page":"e0156161","DOI":"10.1371\/journal.pone.0156161","volume":"11","author":"S Domergue","year":"2016","unstructured":"Domergue S, Bony C, Maumus M, Toupet K, Frouin E, Rigau V, et al. Comparison between stromal vascular fraction and adipose mesenchymal stem cells in remodeling hypertrophic scars. PLoS ONE. 2016;11:e0156161.","journal-title":"PLoS ONE"},{"key":"1605_CR134","doi-asserted-by":"crossref","first-page":"340257","DOI":"10.1155\/2014\/340257","volume":"2014","author":"B Usunier","year":"2014","unstructured":"Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int. 2014;2014:340257.","journal-title":"Stem Cells Int"},{"key":"1605_CR135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1023889805133","volume":"5","author":"MF Burbridge","year":"2002","unstructured":"Burbridge MF, Cog\u00e9 F, Galizzi JP, Boutin JA, West DC, Tucker GC. The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis. 2002;5:215\u201326.","journal-title":"Angiogenesis"},{"key":"1605_CR136","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2017.02.080","volume":"234","author":"E Jin","year":"2017","unstructured":"Jin E, Chae D-S, Son M, Kim S-W. Angiogenic characteristics of human stromal vascular fraction in ischemic hindlimb. Int J Cardiol. 2017;234:38\u201347.","journal-title":"Int J Cardiol."},{"key":"1605_CR137","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000114522.38265.61","volume":"109","author":"V Planat-Benard","year":"2004","unstructured":"Planat-Benard V, Silvestre J-S, Cousin B, Andr\u00e9 M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109:656\u201363.","journal-title":"Circulation"},{"key":"1605_CR138","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCRESAHA.107.159475","volume":"102","author":"DO Traktuev","year":"2008","unstructured":"Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res. 2008;102:77\u201385.","journal-title":"Circ Res."},{"key":"1605_CR139","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/CIRCRESAHA.108.190926","volume":"104","author":"DO Traktuev","year":"2009","unstructured":"Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, Murphy M, et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res. 2009;104:1410\u201320.","journal-title":"Circ Res."},{"key":"1605_CR140","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","volume":"126","author":"M Hellstr\u00f6m","year":"1999","unstructured":"Hellstr\u00f6m M, Kal\u00e9n M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126:3047\u201355.","journal-title":"Development."},{"key":"1605_CR141","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1478-811X-12-26","volume":"12","author":"T Lopatina","year":"2014","unstructured":"Lopatina T, Bruno S, Tetta C, Kalinina N, Porta M, Camussi G. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal. 2014;12:26.","journal-title":"Cell Commun Signal"},{"key":"1605_CR142","doi-asserted-by":"crossref","first-page":"e0117644","DOI":"10.1371\/journal.pone.0117644","volume":"10","author":"L Zhou","year":"2015","unstructured":"Zhou L, Xia J, Qiu X, Wang P, Jia R, Chen Y, et al. In vitro evaluation of endothelial progenitor cells from adipose tissue as potential angiogenic cell sources for bladder angiogenesis. PLoS ONE. 2015;10:e0117644.","journal-title":"PLoS ONE"},{"key":"1605_CR143","doi-asserted-by":"crossref","first-page":"18600","DOI":"10.1074\/jbc.M311643200","volume":"279","author":"J Matsui","year":"2004","unstructured":"Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M. Stem cell factor\/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem. 2004;279:18600\u20137.","journal-title":"J Biol Chem."},{"key":"1605_CR144","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000362276","volume":"51","author":"PC Stapor","year":"2014","unstructured":"Stapor PC, Sweat RS, Dashti DC, Betancourt AM, Murfee WL. Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res. 2014;51:163\u201374.","journal-title":"J Vasc Res"},{"key":"1605_CR145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","volume":"277","author":"P Lindahl","year":"1997","unstructured":"Lindahl P, Johansson BR, Lev\u00e9en P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242\u20135.","journal-title":"Science"},{"key":"1605_CR146","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/acel.12954","volume":"18","author":"F Ascenzi","year":"2019","unstructured":"Ascenzi F, Barberi L, Dobrowolny G, Villa Nova Bacurau A, Nicoletti C, Rizzuto E, et al. Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell. 2019;18:e12954.","journal-title":"Aging Cell"},{"key":"1605_CR147","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2006.01.038","volume":"341","author":"J-H Lee","year":"2006","unstructured":"Lee J-H, Kemp DM. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun. 2006;341:882\u20138.","journal-title":"Biochem Biophys Res Commun."},{"key":"1605_CR148","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00006534-200201000-00030","volume":"109","author":"H Mizuno","year":"2002","unstructured":"Mizuno H, Zuk PA, Zhu M, Lorenz HP, Benhaim P, Hedrick MH. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg .2002;109:199\u2013209.","journal-title":"Plast Reconstr Surg"},{"key":"1605_CR149","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/mt.2009.67","volume":"17","author":"S Goudenege","year":"2009","unstructured":"Goudenege S, Pisani DF, Wdziekonski B, Di Santo JP, Bagnis C, Dani C, et al. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther J Am Soc Gene Ther. 2009;17:1064\u201372.","journal-title":"Mol Ther J Am Soc Gene Ther."},{"key":"1605_CR150","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1242\/jcs.03029","volume":"119","author":"G Di Rocco","year":"2006","unstructured":"Di Rocco G, Iachininoto MG, Tritarelli A, Straino S, Zacheo A, Germani A, et al. Myogenic potential of adipose-tissue-derived cells. J Cell Sci. 2006;119:2945\u201352.","journal-title":"J Cell Sci."},{"key":"1605_CR151","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3727\/000000004773301771","volume":"13","author":"F Bacou","year":"2004","unstructured":"Bacou F, Andalousi RBE, Daussin P-A, Micallef J-P, Levin JM, Chammas M, et al. Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle. Cell Transpl. 2004;13:103\u201311.","journal-title":"Cell Transpl"},{"key":"1605_CR152","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.3390\/ijms21093302","volume":"21","author":"M Zimowska","year":"2020","unstructured":"Zimowska M, Archacka K, Brzoska E, Bem J, Czerwinska AM, Grabowska I, et al. IL-4 and SDF-1 increase adipose tissue-derived stromal cell ability to improve rat skeletal muscle regeneration. Int J Mol Sci. 2020;21:3302.","journal-title":"Int J Mol Sci."},{"key":"1605_CR153","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1084\/jem.20042224","volume":"201","author":"A-M Rodriguez","year":"2005","unstructured":"Rodriguez A-M, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne J-Y, Wdziekonski B, et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med. 2005;201:1397\u2013405.","journal-title":"J Exp Med"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01605-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01605-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01605-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:07:29Z","timestamp":1700604449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01605-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1605"],"URL":"https:\/\/doi.org\/10.1038\/s41420-023-01605-9","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}